Perifosine in Treating Patients With Recurrent Prostate Cancer

NCT00058214 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

25

Enrollment

NIH

Sponsor class

Stopped Did not meet interim stopping criteria for continuation to the second stage.

Conditions

Adenocarcinoma of the Prostate
Recurrent Prostate Cancer
Stage IIB Prostate Cancer
Stage III Prostate Cancer
Stage IV Prostate Cancer

Interventions

DRUG: perifosine
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)